CytomX Therapeutics Net Worth 2014-2020 | CTMX

Interactive chart of historical net worth (market cap) for CytomX Therapeutics (CTMX) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. CytomX Therapeutics net worth as of January 22, 2021 is $0.31B.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.305B $0.057B
CytomX Therapeutics, Inc. is an oncology focused biopharmaceutical company. The Company is engaged in developing Probody(TM) therapeutics for the treatment of cancer. Its pipeline focuses areas consist of Precision cancer immunotherapy and Probody drug conjugates. CytomX Therapeutics, Inc. is headquartered in South San Francisco, California.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $146.724B 15.34
Bristol Myers Squibb (BMY) United States $145.219B 10.35
CSL (CSLLY) Australia $95.499B 0.00
Gilead Sciences (GILD) United States $83.961B 11.16
Vertex Pharmaceuticals (VRTX) United States $62.055B 28.86
Illumina (ILMN) United States $59.111B 81.30
Regeneron Pharmaceuticals (REGN) United States $57.139B 20.27
Moderna (MRNA) United States $52.622B 0.00
Biogen (BIIB) United States $41.567B 7.38
Alexion Pharmaceuticals (ALXN) United States $34.547B 13.76
Seagen (SGEN) United States $33.607B 88.47
BeiGene (BGNE) Cayman Islands $32.554B 0.00
Genmab (GMAB) Denmark $28.231B 33.39
Genmab (GNMSF) Denmark $26.960B 6.21
BioNTech SE (BNTX) Germany $23.855B 0.00
Exact Sciences (EXAS) United States $22.273B 0.00
Incyte (INCY) United States $20.564B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $19.449B 0.00
Alnylam Pharmaceuticals (ALNY) United States $19.373B 0.00
Bio-Rad Laboratories (BIO.B) United States $18.067B 68.51
Horizon Therapeutics Public (HZNP) Ireland $17.090B 24.43
Guardant Health (GH) United States $16.202B 0.00
BioMarin Pharmaceutical (BMRN) United States $15.771B 104.68
ARGENX SE-ADR (ARGX) Netherlands $14.926B 0.00
Bio-Techne Corp (TECH) United States $13.733B 87.82
CRISPR Therapeutics AG (CRSP) Switzerland $13.180B 0.00
QIAGEN (QGEN) Netherlands $12.237B 27.55
Repligen (RGEN) United States $11.414B 161.87
Mirati Therapeutics (MRTX) United States $10.706B 0.00
Twist Bioscience (TWST) United States $9.457B 0.00
Adaptive Biotechnologies (ADPT) United States $9.165B 0.00
Denali Therapeutics (DNLI) United States $9.018B 0.00
Fate Therapeutics (FATE) United States $8.696B 0.00
Ascendis Pharma (ASND) Denmark $8.272B 0.00
ACADIA Pharmaceuticals (ACAD) United States $8.268B 0.00
Ultragenyx Pharmaceutical (RARE) United States $8.124B 0.00
Novavax (NVAX) United States $7.792B 0.00
Sarepta Therapeutics (SRPT) United States $7.648B 0.00
Acceleron Pharma (XLRN) United States $7.510B 0.00
Galapagos (GLPG) Belgium $7.322B 0.00
Exelixis (EXEL) United States $6.614B 44.42
Halozyme Therapeutics (HALO) United States $6.421B 296.88
NeoGenomics (NEO) United States $6.139B 1843.00
SWEDISH ORP BIO (BIOVF) Sweden $5.932B 17.35
Emergent Biosolutions (EBS) United States $5.833B 19.14
Certara (CERT) United States $5.695B 0.00
Blueprint Medicines (BPMC) United States $5.565B 18.42
Vir Biotechnology (VIR) United States $5.401B 0.00
Beam Therapeutics (BEAM) United States $5.369B 0.00
Amicus Therapeutics (FOLD) United States $5.269B 0.00
Eidos Therapeutics (EIDX) United States $4.762B 0.00
China Biologic Products (CBPO) China $4.664B 30.23
Arena Pharmaceuticals (ARNA) United States $4.459B 0.00
Intellia Therapeutics (NTLA) United States $4.289B 0.00
Insmed (INSM) United States $4.287B 0.00
Arvinas (ARVN) United States $4.083B 0.00
Editas Medicine (EDIT) United States $3.999B 0.00
MorphoSys AG (MOR) Germany $3.928B 142.19
Reata Pharmaceuticals (RETA) United States $3.790B 0.00
Legend Biotech (LEGN) United States $3.730B 0.00
Alkermes (ALKS) Ireland $3.417B 33.55
I-Mab (IMAB) China $3.119B 0.00
Bluebird Bio (BLUE) United States $3.109B 0.00
Global Blood Therapeutics (GBT) United States $2.959B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.690B 0.00
Sorrento Therapeutics (SRNE) United States $2.624B 0.00
Intra-Cellular Therapies (ITCI) United States $2.620B 0.00
Amarin (AMRN) Ireland $2.468B 0.00
Arcus Biosciences (RCUS) United States $2.405B 0.00
Zymeworks (ZYME) Canada $2.380B 0.00
Seres Therapeutics (MCRB) United States $2.205B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.187B 0.00
Ligand Pharmaceuticals (LGND) United States $2.169B 56.20
BAVARIAN NORDIC (BVNRY) Denmark $2.057B 17.02
Sangamo Therapeutics (SGMO) United States $2.049B 0.00
Myriad Genetics (MYGN) United States $2.008B 0.00
PHARMA MAR SA (PHMMF) Spain $1.959B 0.00
NGM Biopharmaceuticals (NGM) United States $1.925B 0.00
Revance Therapeutics (RVNC) United States $1.889B 0.00
Genetron Holdings (GTH) China $1.866B 0.00
Viela Bio (VIE) United States $1.861B 0.00
NantKwest (NK) United States $1.847B 0.00
Vericel (VCEL) United States $1.824B 0.00
Scholar Rock Holding (SRRK) United States $1.786B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.728B 0.00
UniQure (QURE) Netherlands $1.717B 0.00
Precigen (PGEN) United States $1.695B 0.00
Castle Biosciences (CSTL) United States $1.626B 0.00
REGENXBIO (RGNX) United States $1.597B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $1.562B 0.00
Heska (HSKA) United States $1.548B 0.00
Inovio Pharmaceuticals (INO) United States $1.542B 0.00
Codexis (CDXS) United States $1.516B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.498B 0.00
Zealand Pharma (ZEAL) Denmark $1.496B 0.00
Cytokineticsorporated (CYTK) United States $1.422B 0.00
Mersana Therapeutics (MRSN) United States $1.373B 0.00
Travere Therapeutics (TVTX) United States $1.372B 0.00
Zealand Pharma (ZLDPF) Denmark $1.353B 0.00
Cellectis S.A (CLLS) France $1.343B 0.00
Adverum Biotechnologies (ADVM) United States $1.308B 0.00
Coherus BioSciences (CHRS) United States $1.296B 8.57
Alector (ALEC) United States $1.285B 0.00
Bionano Genomics (BNGO) United States $1.267B 0.00
Antibe Therapeutics (ATBPF) Canada $1.253B 0.00
Frequency Therapeutics (FREQ) United States $1.208B 0.00
Northwest Biotherapeutics (NWBO) United States $1.186B 0.00
Epizyme (EPZM) United States $1.157B 0.00
Mesoblast (MESO) Australia $1.114B 0.00
Athenex (ATNX) United States $1.073B 0.00
Lexicon Pharmaceuticals (LXRX) United States $1.028B 0.00
Sutro Biopharma (STRO) United States $1.010B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.992B 0.00
MiMedx (MDXG) United States $0.979B 0.00
Gritstone Oncology (GRTS) United States $0.965B 0.00
Cara Therapeutics (CARA) United States $0.946B 0.00
Morphic Holding (MORF) United States $0.927B 0.00
Intercept Pharmaceuticals (ICPT) United States $0.926B 0.00
Pliant Therapeutics (PLRX) United States $0.925B 0.00
Pharming Group (PHGUF) Netherlands $0.908B 24.17
Protagonist Therapeutics (PTGX) United States $0.901B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.871B 0.00
Compugen (CGEN) Israel $0.865B 0.00
Merus (MRUS) Netherlands $0.860B 0.00
Kadmon Holdings (KDMN) United States $0.831B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.796B 40.42
MannKind (MNKD) United States $0.793B 0.00
Avid Bioservices (CDMO) United States $0.773B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.771B 0.00
VBI Vaccines (VBIV) United States $0.746B 0.00
Precision BioSciences (DTIL) United States $0.713B 0.00
DBV Technologies S.A (DBVT) France $0.712B 0.00
Celldex Therapeutics (CLDX) United States $0.709B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.705B 0.00
Syros Pharmaceuticals (SYRS) United States $0.688B 0.00
AnaptysBio (ANAB) United States $0.686B 0.00
Albireo Pharma (ALBO) United States $0.665B 0.00
Curis (CRIS) United States $0.652B 0.00
Agenus (AGEN) United States $0.650B 0.00
Sinovac Biotech (SVA) China $0.640B 35.94
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.639B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.608B 0.00
AquaBounty Technologies (AQB) United States $0.608B 0.00
MeiraGTx Holdings (MGTX) United States $0.587B 0.00
Affimed (AFMD) Germany $0.581B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.578B 0.00
Cel-Sci (CVM) United States $0.564B 0.00
Clovis Oncology (CLVS) United States $0.563B 0.00
Anika Therapeutics (ANIK) United States $0.558B 75.44
Dynavax Technologies (DVAX) United States $0.555B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.545B 0.00
Prothena (PRTA) Ireland $0.533B 0.00
Pandion Therapeutics (PAND) United States $0.532B 0.00
Five Prime Therapeutics (FPRX) United States $0.525B 0.00
Geron (GERN) United States $0.518B 0.00
FORTE BIOSCIENC (FBRX) United States $0.501B 0.00
Spero Therapeutics (SPRO) United States $0.483B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.480B 0.00
Amryt Pharma (AMYT) United Kingdom $0.480B 0.00
WAVE Life Sciences (WVE) Singapore $0.477B 0.00
Starpharma Holdings (SPHRY) Australia $0.456B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.448B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.439B 0.00
UROGEN PHARMA (URGN) United States $0.437B 0.00
AC Immune SA (ACIU) Switzerland $0.433B 0.00
XOMA (XOMA) United States $0.426B 0.00
BioDelivery Sciences (BDSI) United States $0.426B 20.05
Puma Biotechnology (PBYI) United States $0.421B 0.00
Kala Pharmaceuticals (KALA) United States $0.418B 0.00
Cue Biopharma (CUE) United States $0.415B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.414B 0.00
Cardiff Oncology (CRDF) United States $0.402B 0.00
ANI Pharmaceuticals (ANIP) United States $0.393B 9.99
Verastem (VSTM) United States $0.372B 0.00
Innate Pharma S.A (IPHA) France $0.371B 0.00
Selecta Biosciences (SELB) United States $0.363B 0.00
Athersys (ATHX) United States $0.362B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.357B 0.00
Cellular Biomedicine (CBMG) United States $0.351B 0.00
AMMO (POWW) United States $0.349B 0.00
NextCure (NXTC) United States $0.347B 0.00
Trevena (TRVN) United States $0.339B 0.00
Arbutus Biopharma (ABUS) United States $0.336B 0.00
Voyager Therapeutics (VYGR) United States $0.324B 8.32
Fortress Biotech (FBIO) United States $0.323B 0.00
Bellus Health (BLU) Canada $0.308B 0.00
Kamada (KMDA) Israel $0.300B 14.04
ChromaDex (CDXC) United States $0.297B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.290B 0.00
PDL BioPharma (PDLI) United States $0.282B 0.00
CorMedix Inc (CRMD) United States $0.277B 0.00
HOOKIPA Pharma (HOOK) United States $0.267B 0.00
OSMOTICA PHARM (OSMT) United States $0.267B 0.00
IBio (IBIO) United States $0.266B 0.00
Palatin Technologies (PTN) United States $0.264B 0.00
Aptinyx (APTX) United States $0.254B 0.00
Checkpoint Therapeutics (CKPT) United States $0.253B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.240B 0.00
Cerecor (CERC) United States $0.231B 0.00
Cogent Biosciences (COGT) United States $0.230B 0.00
ADMA Biologics Inc (ADMA) United States $0.229B 0.00
Theratechnologies (THTX) Canada $0.221B 0.00
Eton Pharmaceuticals (ETON) United States $0.221B 0.00
GENFIT S.A (GNFT) France $0.216B 0.00
TELA Bio (TELA) United States $0.210B 0.00
Idera Pharmaceuticals (IDRA) United States $0.209B 0.00
Exicure (XCUR) United States $0.202B 0.00
POXEL SA FRANCE (PXXLF) France $0.197B 0.00
Abeona Therapeutics (ABEO) United States $0.195B 0.00
Biofrontera AG (BFRA) Germany $0.195B 0.00
Strongbridge Biopharma (SBBP) United States $0.194B 0.00
VolitionRX (VNRX) United States $0.193B 0.00
Pluristem Therapeutics (PSTI) Israel $0.188B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.187B 0.00
Nicox SA (NICXF) France $0.182B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.180B 0.00
Clearside Biomedical (CLSD) United States $0.177B 0.00
Kindred Biosciences (KIN) United States $0.176B 0.00
Oncobiologics (OTLK) United States $0.167B 0.00
DiaMedica Therapeutics (DMAC) United States $0.165B 0.00
Evogene (EVGN) Israel $0.161B 0.00
Lumos Pharma (LUMO) United States $0.159B 0.00
VTv Therapeutics (VTVT) United States $0.157B 0.00
Dyadic (DYAI) United States $0.155B 0.00
Protalix BioTherapeutics (PLX) Israel $0.154B 0.00
Orgenesis (ORGS) United States $0.153B 316.50
Pieris Pharmaceuticals (PIRS) United States $0.152B 0.00
Cocrystal Pharma (COCP) United States $0.152B 0.00
Prometic Life Sciences (LMNL) Canada $0.149B 0.00
Synlogic (SYBX) United States $0.149B 0.00
Catalyst Biosciences (CBIO) United States $0.147B 0.00
Aptevo Therapeutics (APVO) United States $0.145B 0.00
Enzo Biochem (ENZ) United States $0.143B 0.00
TRACON Pharmaceuticals (TCON) United States $0.139B 0.00
Liquidia Technologies (LQDA) United States $0.130B 0.00
Prima BioMed (IMMP) Australia $0.129B 0.00
PHASEBIO PHARMA (PHAS) United States $0.123B 0.00
Vascular Biogenics (VBLT) Israel $0.123B 0.00
Applied Genetic Technologies (AGTC) United States $0.121B 0.00
Ecology Coatings (ABVC) United States $0.121B 0.00
AIT Therapeutics (XAIR) United States $0.119B 0.00
Celyad SA (CYAD) Belgium $0.118B 0.00
Seelos Therapeutics (SEEL) United States $0.116B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.116B 0.00
Cyclerion Therapeutics (CYCN) United States $0.113B 0.00
Novogen (KZIA) Australia $0.111B 0.00
Organovo Holdings (ONVO) United States $0.108B 0.00
Cidara Therapeutics (CDTX) United States $0.105B 0.00
Aytu Bioscience (AYTU) United States $0.104B 0.00
Windtree Therapeutics (WINT) United States $0.096B 0.00
Adocia (ADOCY) France $0.091B 0.00
ARAVIVE, INC (ARAV) United States $0.091B 0.00
Stealth BioTherapeutics (MITO) United States $0.090B 43.00
CytRx (CYTR) United States $0.089B 0.00
CollPlant Holdings (CLGN) Israel $0.082B 0.00
Genetic Technologies (GENE) Australia $0.074B 0.00
Purple Biotech (PPBT) Israel $0.073B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.071B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.069B 0.00
AnPac Bio-Medical Science (ANPC) China $0.067B 0.00
Emmaus Life Sciences (EMMA) United States $0.066B 0.00
Celsion (CLSN) United States $0.065B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.062B 0.00
Vaccinex (VCNX) United States $0.060B 0.00
Acorda Therapeutics (ACOR) United States $0.058B 0.00
Appili Therapeutics (APLIF) Canada $0.056B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.056B 0.00
BioCardia (BCDA) United States $0.055B 0.00
Pulmatrix (PULM) United States $0.054B 0.00
Cleveland BioLabs (CBLI) United States $0.054B 0.00
Edesa Biotech (EDSA) Canada $0.054B 0.00
Yumanity Therapeutics (YMTX) United States $0.053B 0.00
Advaxis (ADXS) United States $0.052B 0.00
Happiness Biotech Group (HAPP) China $0.052B 0.00
Soligenix (SNGX) United States $0.050B 0.00
AEterna Zentaris (AEZS) United States $0.048B 0.00
Chanticleer Holdings (SONN) United States $0.046B 0.00
Alimera Sciences (ALIM) United States $0.045B 0.00
Spherix (AIKI) United States $0.042B 0.00
IMMURON (IMRN) Australia $0.042B 0.00
ATyr Pharma (LIFE) United States $0.040B 0.00
Prana Biotechnology (ATHE) Australia $0.039B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.036B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.030B 0.00
Neuralstem (SNCA) United States $0.024B 0.00
Titan Pharmaceuticals (TTNP) United States $0.023B 0.00
Cesca Therapeutics (THMO) United States $0.021B 0.00
GeoVax Labs (GOVX) United States $0.019B 0.00
Invo BioScience (INVO) United States $0.015B 0.00
Lexaria Bioscience (LEXX) Canada $0.015B 0.00
BioPharmX (TMBR) United States $0.013B 0.00
CTD Holdings (CYTH) United States $0.010B 0.00
Enveric Biosciences (ENVB) United States $0.007B 0.00
Benitec Biopharma (BNTC) United States $0.004B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00
Zai Lab (ZLAB) China $0.000B 0.00